Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China flag China · Delayed Price · Currency is CNY
12.94
+0.10 (0.78%)
Apr 29, 2026, 3:04 PM CST

SHE:300705 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,0103,1112,9302,6912,3251,627
Other Revenue
--1.151.020.890.82
3,0103,1112,9312,6932,3261,628
Revenue Growth (YoY)
-0.85%6.15%8.85%15.75%42.92%66.40%
Cost of Revenue
855.11841.68790.88621.79522.52365.47
Gross Profit
2,1552,2692,1402,0711,8041,262
Selling, General & Admin
1,4661,4701,3311,4051,285878.31
Research & Development
189.5218.41245.97254.12201.26146.26
Other Operating Expenses
-5.36-2.6525.1528.4725.8721.04
Operating Expenses
1,6501,6861,5981,6961,5251,051
Operating Income
505.33583.19541.62375.12278.84211.22
Interest Expense
-0.17--18.63-11.06-18.42-16.01
Interest & Investment Income
--8.567.676.85.82
Currency Exchange Gain (Loss)
---0.26-0.42-0.27-0.14
Other Non Operating Income (Expenses)
-28.56-25.07-0.58-0.29-0.24-0.19
EBT Excluding Unusual Items
476.61558.12530.71371.02266.71200.7
Gain (Loss) on Sale of Investments
-1.4-0.96----
Gain (Loss) on Sale of Assets
0.050.05-0.03-0.02
Asset Writedown
-31-30.85-1.92-1.46-1.3-1.9
Other Unusual Items
--43.432.5724.8127.38
Pretax Income
444.26526.36572.19402.16290.22226.19
Income Tax Expense
45.7356.3359.8233.920.5221.94
Earnings From Continuing Operations
398.52470.04512.38368.26269.7204.25
Minority Interest in Earnings
5.262.78----
Net Income
403.78472.82512.38368.26269.7204.25
Net Income to Common
403.78472.82512.38368.26269.7204.25
Net Income Growth
-21.21%-7.72%39.13%36.55%32.05%148.29%
Shares Outstanding (Basic)
496493488478460461
Shares Outstanding (Diluted)
501498493504460461
Shares Change (YoY)
0.93%1.02%-2.34%9.55%-0.15%0.13%
EPS (Basic)
0.810.961.050.770.590.44
EPS (Diluted)
0.810.951.040.730.590.44
EPS Growth
-21.94%-8.65%42.47%24.64%32.24%147.98%
Free Cash Flow
-64.97-5.83348.54.37-144.3964.94
Free Cash Flow Per Share
-0.13-0.010.710.01-0.310.14
Dividend Per Share
--0.3130.2290.1690.133
Dividend Growth
--36.49%36.00%26.67%507.76%
Gross Margin
71.59%72.94%73.01%76.91%77.54%77.55%
Operating Margin
16.79%18.75%18.48%13.93%11.99%12.98%
Profit Margin
13.41%15.20%17.48%13.68%11.59%12.55%
Free Cash Flow Margin
-2.16%-0.19%11.89%0.16%-6.21%3.99%
EBITDA
637.45707.33633.88446.5338.49264.8
EBITDA Margin
21.18%22.74%21.63%16.58%14.55%16.27%
D&A For EBITDA
132.11124.1492.2671.3759.6453.58
EBIT
505.33583.19541.62375.12278.84211.22
EBIT Margin
16.79%18.75%18.48%13.93%11.99%12.98%
Effective Tax Rate
10.29%10.70%10.45%8.43%7.07%9.70%
Revenue as Reported
--2,9312,6932,3261,628
Advertising Expenses
--79.6473.0177.4128.51
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.